| Safety And Efficacy Of Rifabutin In HIV Patients (NCT00810446) | Pfizer | 2009-06-01 |
| Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine (NCT00800670) | McMaster University | 2009-06-01 |
| The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure (NCT00981071) | Armed Forces Capital Hospital, Republic of Korea | 2009-05-01 |
| Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy (NCT00925249) | Walter Reed Army Medical Center | 2009-05-01 |
| Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy (NCT00915330) | Maggiore Bellaria Hospital, Bologna | 2009-05-01 |
| Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults (NCT00871949) | Sequella, Inc. | 2009-04-01 |
| Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya (NCT00850915) | KNCV Tuberculosis Foundation | 2009-04-01 |
| Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients (NCT00805272) | Assistance Publique - Hôpitaux de Paris | 2009-02-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa (NCT00640887) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-02-01 |
| Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children (NCT00604617) | Case Western Reserve University | 2009-01-26 |
| Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus) (NCT02127983) | Liverpool School of Tropical Medicine | 2009-01-01 |
| The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan (NCT01841541) | Liverpool School of Tropical Medicine | 2009-01-01 |
| Efficacy of Antituberculous Therapy in Management of Sarcoidosis (NCT01245036) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2009-01-01 |
| Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis (NCT00816426) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-29 |
| BCG Vaccination Delivered Intradermally, Orally and by Combined Routes (NCT00396370) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-02 |
| A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) (NCT01049282) | Statens Serum Institut | 2008-12-01 |
| Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis (NCT00801606) | All India Institute of Medical Sciences | 2008-12-01 |
| A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) (NCT02109874) | Aeras | 2008-12-01 |
| An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin (NCT00771498) | Oswaldo Cruz Foundation | 2008-11-01 |
| Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers (NCT00797836) | Assistance Publique - Hôpitaux de Paris | 2008-11-01 |
| Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients (NCT00810407) | Pfizer | 2008-11-01 |
| Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis (NCT00474435) | African Poverty Related Infection Oriented Research Initiative | 2008-11-01 |
| Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration (NCT00793702) | Statens Serum Institut | 2008-11-01 |
| Vitamin D in Active Tuberculosis (TB) Study (NCT00788320) | Atlanta VA Medical Center | 2008-10-01 |
| A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers (NCT02043314) | Oswaldo Cruz Foundation | 2008-10-01 |
| Spatial Epidemiology of Tuberculosis (TB) Infection (NCT00780546) | National Taiwan University Hospital | 2008-10-01 |
| Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs (NCT00979290) | E-DA Hospital | 2008-10-01 |
| A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB (NCT02414828) | Aeras | 2008-10-01 |
| Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers (NCT00749034) | Serum Life Science Europe GmbH | 2008-09-01 |
| A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB (NCT02430506) | Aeras | 2008-09-01 |
| Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis (NCT01315301) | Karolinska Institutet | 2008-08-01 |
| A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV (NCT00731471) | University of Oxford | 2008-08-01 |
| A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects (NCT00743470) | Abbott | 2008-08-01 |
| Mentor Mothers: A Sustainable Family Intervention in South African Townships (NCT00972699) | University of California, Los Angeles | 2008-07-01 |
| Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection (NCT00692809) | Ministry of Science and Technology, India | 2008-07-01 |
| Treatment Duration for Abdominal Tuberculosis (NCT01124929) | All India Institute of Medical Sciences | 2008-07-01 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults. (NCT00707967) | GlaxoSmithKline | 2008-06-30 |
| NAT2 in Re-challenge of INH in Patients With Hepatitis (NCT00728546) | National Taiwan University Hospital | 2008-06-01 |
| T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals (NCT00707317) | Tuberculosis Network European Trialsgroup | 2008-06-01 |
| TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. (NCT00741169) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis (NCT00982969) | Armed Forces Capital Hospital, Republic of Korea | 2008-06-01 |
| QuantiFERON Change During Anti-tuberculosis Medication (NCT01038830) | Armed Forces Capital Hospital, Republic of Korea | 2008-05-01 |
| Pulmonary Tuberculosis and Vitamin D (NCT00507000) | Indian Council of Medical Research | 2008-05-01 |
| A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults (NCT02074956) | Aeras | 2008-05-01 |
| Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis (NCT00617643) | Makerere University | 2008-05-01 |
| Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults (NCT00621322) | GlaxoSmithKline | 2008-04-03 |
| Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment (NCT00737724) | Instituto Nacional de Enfermedades Respiratorias | 2008-03-01 |
| Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (NCT00495651) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-03-01 |
| A Study of MVA85A in Healthy Children and Infants (NCT00679159) | University of Oxford | 2008-02-01 |
| Rapid Diagnosis of Pulmonary Tuberculosis (NCT00608790) | University of Cape Town | 2008-02-01 |
| Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients (NCT00620438) | Makerere University | 2008-02-01 |
| Diagnosis of Tuberculosis Infection in HIV Co-infected Children (NCT00541294) | Case Western Reserve University | 2008-01-15 |
| Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison (NCT00767975) | National Taiwan University Hospital | 2008-01-01 |
| Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) (NCT00495326) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-12-01 |
| The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation (NCT00889759) | Armed Forces Capital Hospital, Republic of Korea | 2007-12-01 |
| Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity (NCT00929786) | All India Institute of Medical Sciences | 2007-11-01 |
| A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection (NCT02066428) | Aeras | 2007-11-01 |
| Follow up of Autoantibodies in Active Tuberculosis (NCT00551226) | Tel-Aviv Sourasky Medical Center | 2007-11-01 |
| Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity (NCT00564642) | National Research Institute of Tuberculosis and Lung Disease, Iran | 2007-11-01 |
| Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (NCT00463086) | University of Cape Town | 2007-11-01 |
| Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes? (NCT00756808) | Northwell Health | 2007-10-01 |
| Universal Screening for Tuberculosis and Anemia With the CHICA System (NCT01322841) | Indiana University | 2007-10-01 |
| T-Cell Turnover Following Vaccination With MVA85A (NCT00548444) | University of Oxford | 2007-10-01 |
| Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients (NCT01290081) | National Institute for Health Development, Estonia | 2007-10-01 |
| A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A (NCT00653770) | University of Oxford | 2007-09-01 |
| A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers (NCT00929396) | Statens Serum Institut | 2007-09-01 |
| Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB) (NCT00512330) | University Hospital, Bonn | 2007-08-01 |
| A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination (NCT00653627) | University of Oxford | 2007-08-01 |
| Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti (NCT00120510) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-07-01 |
| A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV (NCT00523458) | Stanford University | 2007-07-01 |
| Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists (NCT00491933) | ASST Fatebenefratelli Sacco | 2007-06-01 |
| TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB). (NCT00449644) | Janssen Infectious Diseases BVBA | 2007-06-01 |
| Innovative Approaches to Tuberculosis Control (NCT00472316) | Johns Hopkins University | 2007-05-01 |
| Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children (NCT00456469) | Liverpool School of Tropical Medicine | 2007-05-01 |
| Immunobiology of Diabetes and Tuberculosis (NCT00568854) | Stanford University | 2007-04-01 |
| Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers (NCT00546273) | Germans Trias i Pujol Hospital | 2007-04-01 |
| Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (NCT01828827) | Global Alliance for TB Drug Development | 2007-03-01 |
| Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients. (NCT00341328) | Ministry of Science and Technology, India | 2007-03-01 |
| Treatment of Latent Tuberculosis Infection With Isoniazid (NCT00293228) | Instituto Nacional de Salud Publica, Mexico | 2007-02-01 |
| A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection (NCT00414414) | Ottawa Hospital Research Institute | 2007-02-01 |
| Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia (NCT00675961) | Brigham and Women's Hospital | 2007-01-01 |
| Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (NCT00533390) | Oswaldo Cruz Foundation | 2007-01-01 |
| A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (NCT00440544) | St George's, University of London | 2007-01-01 |
| Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization (NCT00645697) | Rafic Hariri University Hospital | 2007-01-01 |
| Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin (NCT00483054) | Bamrasnaradura Infectious Diseases Institute | 2007-01-01 |
| The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin (NCT00411996) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-12-01 |
| Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage (NCT00405301) | All India Institute of Medical Sciences | 2006-12-01 |
| Metronidazole for Pulmonary Tuberculosis (South Korea) (NCT00425113) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-01 |
| Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults (NCT00397943) | GlaxoSmithKline | 2006-11-15 |
| The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV (NCT00395720) | University of Oxford | 2006-11-01 |
| Tuberculosis Research Blood Bank (NCT00212498) | NYU Langone Health | 2006-11-01 |
| Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease (NCT00402402) | University Health Network, Toronto | 2006-10-01 |
| Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion (NCT01560078) | All India Institute of Medical Sciences | 2006-09-01 |
| Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers (NCT01585636) | Sequella, Inc. | 2006-09-01 |
| Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment (NCT00332306) | Tuberculosis Research Centre, India | 2006-06-01 |
| Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis (NCT00698334) | All India Institute of Medical Sciences | 2006-04-01 |
| Nutrition, Diabetes and Pulmonary TB/HIV (NCT00311298) | University of Copenhagen | 2006-04-01 |
| Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa (NCT00346476) | CIPRA SA | 2006-04-01 |
| A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. (NCT03202693) | Global Alliance for TB Drug Development | 2006-03-01 |
| TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment (NCT00144417) | Centers for Disease Control and Prevention | 2006-02-01 |